These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3929261)

  • 21. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring viral incidence rates: tools for the implementation of European Union regulations.
    Janssen MP; Cator EA; van der Poel CL; Schaasberg WP; Bonsel GJ; van Hout BA
    Vox Sang; 2009 May; 96(4):298-308. PubMed ID: 19228368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 24. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives by pasteurisation.
    Nowak T; Niedrig M; Bernhardt D; Hilfenhaus J
    Dev Biol Stand; 1993; 81():169-76. PubMed ID: 8174799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-A non-B hepatitis.
    Trepo C; Lindberg J
    Scand J Gastroenterol Suppl; 1982; 77():75-92. PubMed ID: 6812228
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-A, non-B hepatitis.
    Dienstag JL
    Adv Intern Med; 1980; 26():187-233. PubMed ID: 6261548
    [No Abstract]   [Full Text] [Related]  

  • 29. The dominant role of non-A, non-B in the pathogenesis of post-transfusion hepatitis: a clinical assessment.
    Alter HJ
    Clin Gastroenterol; 1980 Jan; 9(1):155-70. PubMed ID: 6772362
    [No Abstract]   [Full Text] [Related]  

  • 30. The significance of the blood-borne viruses: blood banking and transfusion medicine.
    Sherwood WC
    Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The agents of human viral hepatitis, and control of the disease.
    Deinhardt F
    Prog Med Virol; 1984; 30():14-28. PubMed ID: 6087411
    [No Abstract]   [Full Text] [Related]  

  • 33. [Virus inactivation of plasma].
    Schmitt H; Mohr H; Lambrecht B; Knüver-Hopf J
    Beitr Infusionsther; 1991; 28():82-91. PubMed ID: 1725665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation.
    Piët MP; Chin S; Prince AM; Brotman B; Cundell AM; Horowitz B
    Transfusion; 1990 Sep; 30(7):591-8. PubMed ID: 2402772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of non-A, non-B virus infectivity by a beta propiolactone/ultraviolet irradiation treatment and Aerosil adsorption procedure used for preparation of a stabilized human serum.
    Prince AM; Stephan W; Brotman B
    Vox Sang; 1984; 46(2):80-5. PubMed ID: 6322448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation.
    Prince AM; Stephan W; Dichtelmüller H; Brotman B; Huima T
    J Med Virol; 1985 Jun; 16(2):119-25. PubMed ID: 3925077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of hepatitis A virus in plasma products by vapor heating.
    Barrett PN; Meyer H; Wachtel I; Eibl J; Dorner F
    Transfusion; 1997 Feb; 37(2):215-20. PubMed ID: 9051099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Virus inactivation in plasma fractions for therapeutic use].
    Burnouf T; Martinache L; Goudemand M
    Nouv Rev Fr Hematol (1978); 1987; 29(1):93-6. PubMed ID: 3588282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new practice for transfusions in our hospitals. Conversion to use of virus inactivated plasma products].
    Tidsskr Nor Laegeforen; 1988 Aug; 108(22):1630-1. PubMed ID: 3413750
    [No Abstract]   [Full Text] [Related]  

  • 40. [Avoiding the use of not virus-inactivated plasma].
    Evensen SA; Brinch L; Stavem P; Glomstein A; Solheim BG
    Tidsskr Nor Laegeforen; 1992 Aug; 112(18):2389. PubMed ID: 1412247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.